These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 767292)

  • 1. Proceedings: Selective suppression of spleen B lymphocytes following treatment with Escherichia coli lipoproteinpolysaccharide-containing adjuvants.
    Mugraby L; Schiffmann Z; Weiss I; Gery I
    Isr J Med Sci; 1975 Dec; 11(12):1383-4. PubMed ID: 767292
    [No Abstract]   [Full Text] [Related]  

  • 2. Differentiation signal defect of splenic cells from LPS-treated mice.
    Portnoï D; Motta I; Truffa-Bachi P
    Ann Immunol (Paris); 1980; 131D(1):103-9. PubMed ID: 7002015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus tumorigenesis and immunity: influence of immunostimulation and immunodepression.
    Friedman H; Ceglowski WS
    Johns Hopkins Med J Suppl; 1974; 3():187-209. PubMed ID: 4609083
    [No Abstract]   [Full Text] [Related]  

  • 4. Biological activity of bacterial surface components. Immunogenicity and immunomodulatory properties of a bacterial extract from Escherichia coli.
    Bessler WG; Beck P; Konetznick U; Loleit M; Sedelmeier E; Hoffmann P; Strecker M; Stöcklin S
    Arzneimittelforschung; 1991 Mar; 41(3):274-9. PubMed ID: 1867666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function.
    Fidler JM; DeJoy SQ; Gibbons JJ
    J Immunol; 1986 Jul; 137(2):727-32. PubMed ID: 3487580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant effect of endotoxin; antibody response to sheep erythrocytes in mice after transfer of syngeneic lymphoid cells treated with bacterial lipopolysaccharide in vitro.
    Nakano M; Uchiyama T; Saito K
    J Immunol; 1973 Feb; 110(2):408-13. PubMed ID: 4567393
    [No Abstract]   [Full Text] [Related]  

  • 7. Nitrogranulogen-dependent inhibition of antibody synthesis. II. In vivo studies in mice.
    Lagodziński Z; Górski A
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):121-5. PubMed ID: 1804041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current concepts concerning immune tolerance].
    Artsimovich NG; Nastoiashchaia NN
    Usp Sovrem Biol; 1976; 82(6):403-16. PubMed ID: 798437
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular site of action of various adjuvants in antibody responses to hapten-carrier conjugates.
    Hamaoka T; Katz DH
    J Immunol; 1973 Nov; 111(5):1554-63. PubMed ID: 4126779
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunosuppressive effect of L-asparaginase. Cellular and humoral studies].
    Emmerling P; Finger H
    Z Immunitatsforsch Allerg Klin Immunol; 1970 Nov; 140(5):472-81. PubMed ID: 4249814
    [No Abstract]   [Full Text] [Related]  

  • 11. The lack of cellular cooperation in the immune response to E. coli 0127.
    Poe WJ; Michael JG
    J Immunol; 1974 Sep; 113(3):1033-8. PubMed ID: 4607202
    [No Abstract]   [Full Text] [Related]  

  • 12. [Stimulation of B-cell immunity in the nude mice by pidotimod: immunohistochemical stucy of various lymphoid organs].
    Vacca A; Di Stefano R; Caloro D; Ranieri G; Dammacco F
    Drugs Exp Clin Res; 1993; 19 Suppl():23-6. PubMed ID: 8625779
    [No Abstract]   [Full Text] [Related]  

  • 13. Malononitrilamides inhibit T- and B-cell responsiveness.
    Kurrle R; Bartlett R; Ruuth E; Lauffer L; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3053-6. PubMed ID: 8962184
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the immunogenicity of an Escherichia coli extract after oral application in mice.
    Baier W; Sedelmeier EA; Bessler WG
    Arzneimittelforschung; 1997 Aug; 47(8):980-5. PubMed ID: 9296288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response and leukemia virus infection in the mouse.
    Collavo D; Biasi G; Colombatti A; Chieco-Bianchi L
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:296. PubMed ID: 4604562
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunoadjuvant properties of chitosan.
    Marcinkiewicz J; Polewska A; Knapczyk J
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):127-32. PubMed ID: 1804042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The modulating effect of cholera enterotoxin on the immune response.
    Chisari FV; Northrup RS; Chen LC
    J Immunol; 1974 Sep; 113(3):729-39. PubMed ID: 4370486
    [No Abstract]   [Full Text] [Related]  

  • 18. Mode of action of adjuvants: retinol and other lysosome-labilizing agents as adjuvants.
    Spitznagel JK; Allison AC
    J Immunol; 1970 Jan; 104(1):119-27. PubMed ID: 4903997
    [No Abstract]   [Full Text] [Related]  

  • 19. [Specific modification of the immune system with CpG-oligonucleotides].
    Krug A; Hartmann G
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1002-4. PubMed ID: 11555774
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of the extract of Spirostachys venenifera Pax on the immune response in mice.
    Njiro SM
    East Afr Med J; 1998 Oct; 75(10):598-601. PubMed ID: 10065196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.